Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 11816
Affinity DataEC50: 2.55E+3nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 7.50E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 2.75E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 2.75E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 2.75E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 2.75E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 2.75E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 2.55E+3nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: >1.00E+5nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 7.50E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 2.75E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataEC50: 7.50E+4nMAssay Description:This patent does not specify.More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.55E+3nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.75E+4nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 2.75E+4nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 7.50E+4nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 7.50E+4nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 7.50E+4nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 7.50E+4nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 7.50E+4nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that inhibit SARS-CoV-2 3CLpro using our recently described assay (Hattori et al. Nat. Commun. 2021, 12, 66...More data for this Ligand-Target Pair
